Table 1.
Demographic characteristics of patients with bladder cancer, stratified by anesthetic method.
| Variable | Full Cohort (n = 4349) |
Propensity Score-Matched Full Cohort (n = 1164) |
||||
|---|---|---|---|---|---|---|
| Regional (n = 582) |
General (n = 3767) |
p-Value | Regional (n = 582) |
General (n = 582) |
p-Value | |
| Age | 66.75 ± 6.09 | 65.50 ± 6.29 | <0.001 | 66.75 ± 6.09 | 66.50 ± 6.06 | 0.094 |
| Gender | <0.001 | 0.999 | ||||
| Male | 460 (79.04%) | 3131 (71.99%) | 460 (79.04%) | 460 (79.04%) | ||
| Female | 122 (20.96%) | 1218 (28.01%) | 122 (20.96%) | 122 (20.96%) | ||
| Medical history | ||||||
| Hypertension | 212 (36.45%) | 1476 (39.19%) | 0.001 | 212 (36.45%) | 212 (36.45%) | 0.999 |
| Diabetes mellitus | 82 (14.01%) | 557 (14.78%) | 0.180 | 82 (14.01%) | 82 (14.01%) | 0.999 |
| Myocardial infarction | 10 (1.65%) | 67 (1.78%) | 0.519 | 10 (1.65%) | 10 (1.65%) | 0.999 |
| Cerebral vascular disease | 55 (9.49%) | 377 (10.02%) | 0.281 | 55 (9.49%) | 55 (9.49%) | 0.999 |
| Congestive heart failure | 15 (2.52%) | 90 (2.40%) | 0.660 | 15 (2.52%) | 15 (2.52%) | 0.999 |
| Renal disease | 30 (5.20%) | 311 (8.25%) | <0.001 | 30 (5.20%) | 32 (5.50%) | 0.453 |
| Dementia | 26 (4.42%) | 1772 (4.57%) | 0.668 | 26 (4.42%) | 26 (4.42%) | 0.999 |
| Liver disease | 15 (2.52%) | 90 (2.40%) | 0.642 | 15 (2.52%) | 15 (2.52%) | 0.999 |
| COPD | 79 (13.62%) | 520 (13.80) | 0.766 | 79 (13.62%) | 79 (13.62%) | 0.999 |
| Follow-up (day) | 1607.05 ± 651.74 | 1598.93 ± 655.66 | 1607.05 ± 651.74 | 1606.19 ± 652.64 | ||
| Recurrence | 107 (18.38%) | 710 (18.85%) | 0.451 | 107 (18.38%) | 108 (18.56%) | 0.613 |
Data is presented as the mean ± SD and number of patients (%). SD: standard deviation, COPD: chronic obstructive pulmonary disease.